<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02677532</url>
  </required_header>
  <id_info>
    <org_study_id>APERIVIP</org_study_id>
    <nct_id>NCT02677532</nct_id>
  </id_info>
  <brief_title>Epidural Versus Wound Infusion Plus Morphine Bolus in Open Abdominal Aortic Aneurysm Repair</brief_title>
  <acronym>APERIVIP</acronym>
  <official_title>Analgesia Postoperatoria Mediante Catetere Perdurare e Analgesia Postoperatoria Mediante Infusione Continua Periferia Nell'Intervento Chirurgico Per Riparazione Chirurgica di Aneurismi Dell'Aorta Addominale: Tecniche a Confronto</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Genova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Genova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine wether continuous wound infusion with local anaesthetic
      plus a single dose intravenous morphine is non-inferior to postoperative analgesia provided
      with continuous thoracic epidural infusion of local anaesthetic plus opiate, in patients
      undergoing open abdominal aortic aneurism repair.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average postoperative pain assessed with numeric rating scale (NRS) in the first 48 hours</measure>
    <time_frame>Average of the NRS recorded at the different time-points (up to 48 hours after emergence from general anaesthesia)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for rescue doses of morphine at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
    <description>Need for a bolus of 5 mg intravenous morphine to relief pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients requiring oxygen administration at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that have restored bowel function at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
    <description>Time to first stool analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients whose urinary catheter was removed at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
    <description>Time to catheter removal analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that have restored ability to walk at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-invasive blood pressure (mmHg) at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
    <description>Blood pressure (systolic, diastolic, mean in mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Follow-up of up to 3 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate (bpm) at each time-point</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea and vomiting</measure>
    <time_frame>0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of postoperative cardiovascular adverse events</measure>
    <time_frame>Intra-hospital follow-up of up to 3 months after surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of postoperative pulmonary complications</measure>
    <time_frame>Intra-hospital follow-up of up to 3 months after surgery</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Epidural infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic epidural bolus of 10 ml levobupivacaine 0.25% plus sufentanil 0.15 mcg/kg before end of surgery, followed by continuous epidural infusion of 0.12% levobupivacaine plus 0.4 mcg/ml at 5 ml/h infusion rate for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous slow bolus of 10 mg morphine, wound infiltration with 10 ml levobupivacaine 0.5%, followed by pre-peritoneal continuous wound infusion of levobupivacaine 0.25% at 4 ml/h infusion rate for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>1 g every 8 hours</description>
    <arm_group_label>Epidural infusion</arm_group_label>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine wound infiltration</intervention_name>
    <description>Wound infiltration with 10 ml levobupivacaine 0.5%</description>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine epidural bolus</intervention_name>
    <description>Epidural bolus of 10 ml 0.25% levobupivacaine</description>
    <arm_group_label>Epidural infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil epidural bolus</intervention_name>
    <description>Epidural bolus of 0.15 mcg/kg sufentanil</description>
    <arm_group_label>Epidural infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Intravenous slow bolus of 10 mg morphine</description>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural catheter placement</intervention_name>
    <description>Thoracic epidural catheter placement in the T7-T8 or T8-T9 intervertebral space</description>
    <arm_group_label>Epidural infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wound infusion catheters placement</intervention_name>
    <description>Pre-peritoneal placement of two catheters for wound infusion</description>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine plus sufentanil epidural infusion</intervention_name>
    <description>Epidural infusion of levobupivacaine 0.12% plus sufentanil 0.4 mcg/ml at 4 ml/h for 48 h</description>
    <arm_group_label>Epidural infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine wound infusion</intervention_name>
    <description>Wound infusion with levobupivacaine 0.25% at 4 ml/h for 48 h</description>
    <arm_group_label>Wound infusion plus morphine bolus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for elective open aortic aneurism repair

        Exclusion Criteria:

          -  Patient refusal

          -  Platelet count &lt; 80*10^3/mcL

          -  International Normalised Ratio &gt; 1.5

          -  Other contraindications to the placement of epidural catheter, including ongoing anti
             platelet or anticoagulant treatment not suspended according to national guidelines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UO Anestesia e Terapia Intensiva, IRCCS AOU San-Martino IST</name>
      <address>
        <city>Genova</city>
        <zip>16100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2016</study_first_submitted>
  <study_first_submitted_qc>February 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2016</study_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Genova</investigator_affiliation>
    <investigator_full_name>Paolo Pelosi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

